Dr. Christophe Caux is Director of Research (Inserm) and co-head of a research team at the Lyon Cancer Research Centre (CRCL) located in the Leon Berard Cancer Centre Hospital. He is an expert in dendritic cells, including the plasmacytoid subset, and develops a translational research program in tumour immunology and immunotherapy strategies.
EFS
(Etablissement Français du Sang – French Blood Bank) transferred the PDC*vac technology to PDC*line Pharma, and provides us with privileged access to its research and GMP-compliant manufacturing infrastructures.